Braxia Scientific Corp.

DB:4960 Stock Report

Market Cap: €936.5k

Braxia Scientific Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Roger McIntyre

Chief executive officer

CA$170.5k

Total compensation

CEO salary percentage100.0%
CEO tenure4.5yrs
CEO ownership5.2%
Management average tenureno data
Board average tenure3.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Roger McIntyre's remuneration changed compared to Braxia Scientific's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-CA$10m

Sep 30 2023n/an/a

-CA$11m

Jun 30 2023n/an/a

-CA$13m

Mar 31 2023CA$238kCA$238k

-CA$13m

Dec 31 2022n/an/a

-CA$12m

Sep 30 2022n/an/a

-CA$13m

Jun 30 2022n/an/a

-CA$12m

Mar 31 2022CA$300kCA$300k

-CA$12m

Dec 31 2021n/an/a

-CA$8m

Sep 30 2021n/an/a

-CA$7m

Jun 30 2021n/an/a

-CA$7m

Mar 31 2021CA$277kCA$277k

-CA$88m

Mar 31 2020CA$119kCA$119k

-CA$3m

Compensation vs Market: Roger's total compensation ($USD122.17K) is below average for companies of similar size in the German market ($USD490.71K).

Compensation vs Earnings: Roger's compensation has been consistent with company performance over the past year.

CEO

Roger McIntyre

4.5yrs

Tenure

CA$170,500

Compensation

Dr. Roger S. McIntyre, MD., FRCPC., is Chief Executive Officer and Director of Braxia Scientific Corp. since May 11, 2020 and July 22, 2020 respectively and serves as its Chairman of the Board since Octobe...

Board Members

NamePositionTenureCompensationOwnership
Roger McIntyre
Chairman & CEO4.3yrsCA$170.50k5.17%
€ 48.4k
Peter Rizakos
CFO & Directorless than a yearCA$134.04kno data
Jerry Habuda
Independent Director5.3yrsno datano data
Leann Taylor
Director2.2yrsno datano data

3.3yrs

Average Tenure

Experienced Board: 4960's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/11/03 20:02
End of Day Share Price 2024/08/06 00:00
Earnings2023/12/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Braxia Scientific Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution